Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola) (Q66922166)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125984

24 August 2022

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(75)80002-5

6 October 2023

J. C. Ruckdeschel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125984

24 August 2022

K. D. Graziano

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125984

24 August 2022

M. R. Mardiney

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125984

24 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1125984

24 August 2022

publication date

1 May 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.elsevier.com/content/article/PII:S0008874975800025?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(75)80002-5

https://api.elsevier.com/content/article/PII:S0008874975800025?httpAccept=text/plain

6 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(75)80002-5

6 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

11-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Clinical Epidemiology of Sporadic Measles in a Highly Immunized Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Measles as an index of immunological function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Use of Edmonston attenuated measles strain. A summary of three years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Dysgammaglobulinaemia complicated by disseminated measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

EFFECTS OF MEASLES, GAMMA-GLOBULIN-MODIFIED MEASLES AND VACCINE MEASLES ON THE TUBERCULIN TEST

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Effect of Measles Immunization on Tuberculin Hypersensitivity and <i>in vitro</i> Lymphocyte Reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Abnormalities in lymphocyte proliferation in classical and atypical measles infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Cellular and humoral responses to measles in subacute sclerosing panencephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Subtle Immunologic Abnormalities in Four Boys with Subacute Sclerosing Panencephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

The in vitro transformation of frozen-stored lymphocytes in the mixed lymphocyte reaction and in culture with phytohemagglutinin and specific antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Parameters for effective use of synthetic double stranded polynucleotides in the amplification of immunologically induced lymphocyte tritiated thymidine incorporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Hemagglutination and hemagglutination-inhibition with measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Recurrent viral infection (reinfection).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

Selective suppression of delayed hypersensitivity by the induction of immunologic tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

In vitro studies of the suppression of delayed hypersensitivity by the induction of partial tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

The mechanism of immunological paralysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2875%2980002-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Journal of Experimental Medicine

135

398

Parish

1971

1 reference

https://api.crossref.org/works/10.1016/S0008-8749(75)80002-5

6 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1125984%20AND%20SRC:MED&resulttype=core&format=json